CLOSE X
Algo Trading
Home

Blogs

Stock Market Blogs

Rupee Under Pressure: How U.S. Tariff Threats Are Shaking Indian Markets July 17 2025Market Update

Visit Count: 1114

The Indian rupee has recently found itself in choppy waters. What began as a mild currency dip is now turning into a broader concern, thanks to renewed US tariff threats and a firming US dollar. For investors, policymakers, and market participants, the question is no longer if the rupee will come under pressure, but how much more.

On July 14, the rupee slipped to Rs 85.98 against the dollar, its weakest level in over two weeks. While the drop may seem modest, the drivers behind it point to deeper turbulence. US President Donald Trump has hinted at imposing high tariffs—possibly over 200%—on pharmaceutical imports if elected, and India, a key supplier of generics to the US, finds itself squarely in the spotlight.

The Dollar Tightens, the Rupee Wobbles

The pressure on the rupee isn’t just political—it's also economic. US inflation rose by 0.3% in June, leading traders to scale back bets on Fed rate cuts. This made the dollar stronger globally, pushing the dollar index near 98.6—a three-week high. A stronger dollar makes emerging market currencies like the rupee less attractive, leading to outflows.

At the same time, India’s retail inflation cooled to a six-year low of 2%, reinforcing expectations that the RBI may continue its dovish stance. But this widening interest rate gap between India and the US further erodes rupee strength.

Tariffs: The Wild Card

While India hasn't been directly hit by new US tariffs yet, the rhetoric is enough to spook the markets. Trump’s recent comments suggest that the US may impose hefty tariffs on pharma imports. India, the world’s third-largest supplier of drugs by volume and the leading exporter of generics to the US, has a lot at stake.

Indian pharmaceutical companies generate a significant chunk of their revenue from the US market. Any disruption could hurt earnings, valuations, and ultimately, investor sentiment.

What’s Next for the Rupee?

Analysts suggest that if the Rs 86 mark is breached, stop-loss triggers could accelerate the fall. RBI is expected to step in selectively through public sector banks to smooth volatility, but may not defend any specific level aggressively.

A lot now depends on US–India trade negotiations and the Fed's upcoming commentary. For Indian businesses and investors, it’s a moment to stay watchful — because currency stress, like inflation, can seep into every corner of the economy.

Disclaimer

This blog is purely for educational purposes and should not be considered investment advice. Please do your own research or consult a registered financial advisor before making any investment decisions.

COMMENTS
Form
Categories
Blog Enquiry

Prevent Unauthorized Transactions in your demat and trading account --> Update your Mobile Number/Email id with your Depository Participant and Stock Broker. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat/trading account directly from CDSL and Stock Exchanges on the same day.........issued in the interest of investors...

1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

2. Update your Mobile Number & Email Id with your Stock Broker/ Depository Participant and receive OTP directly from Depository on your Email Id and/ or Mobile Number to create pledge.

3. Pay 20% upfront margin of the transaction value to trade in cash market segment.

4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued by NSE vide. Circular No. NSE/INSP/45191 dated: July 31, 2020 and NSE/INSP/45534 and BSE vide Notice No. 20200731-7, dated: July 31, 2020 and 20200831- 45 dated: August 31, 2020 and dated: August 31, 2020 and other guidelines issued from time to time in this regard.

5. Check your Securities/ MF/ Bonds in the Consolidated Account Statement issued by NSDL/ CDSL every month.

6. Risk disclosures RISK DISCLOSURES ON DERIVATIVES:

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html
We believe that an educated investor is a protected investor !!!

"As per the directives of CDSL and esteemed Exchanges, it has been made mandatory for every client to furnish their latest KYC details viz. Valid Mobile No., Email- Id & Income range on or before 31.05.2021 else your Account will be marked as Non Compliant and will be Freezed till the compliance of such requirement."
"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
Dear Investor if you wish to revoke your un-executed eDis mandate, please mail us with ISIN and quantity on dp@indiratrade.com by today EOD."
REGISTRATION NOS:

INDIRA SECURITIES PRIVATE LIMITED (SEBI REG.NO.):NSE TMID: 12866, BSE TMID: 663, CDSL DPID: 17000 SEBI REG. NO.: INZ000188930, MCX TM ID: 56470, NCDEX TM ID: 01277, CDSL REG. NO.: IN-DP-90-2015, CIN: U67120MH1996PTC160201, RA SEBI REG. No.: INH000023269

DISCLAIMER:

"INVESTMENT IN SECURITIES MARKET ARE SUBJECT TO MARKET RISKS, READ ALL THE RELATED DOCUMENTS CAREFULLY BEFORE INVESTING."

INVESTORS GRIEVANCE

Vimalesh Ajmera. Email: compliance@indiratrade.com. Call : 0731-4797275

Investor grievance complaint : complaint@indiratrade.com

INVESTOR CHARTER

For Voluntary Freezing/Blocking of Trading Account you can mail us at stoptrade@indiratrade.com or call us at 9109937435.